Volume 5 (Issue 1, 2, 3) 2020
Share on whatsapp
Share on twitter
Share on facebook
-
Current off-label Pharmacotherapeutics in the management of novel coronavirus disease (COVID-19) https://doi.org/10.37881/1.5112020, Volume 5, Issue 1 (January-April) [Download Full PDF]
- Current off-label Pharmacotherapeutics in the management of novel coronavirus disease (COVID-19) https://doi.org/10.37881/1.511
2020, Volume 5, Issue 1 (January-April) [Download Full PDF]
- Current off-label Pharmacotherapeutics in the management of novel coronavirus disease (COVID-19) https://doi.org/10.37881/1.511
2020, Volume 5, Issue 1 (January-April) [Download Full PDF]
- Current off-label Pharmacotherapeutics in the management of novel coronavirus disease (COVID-19) https://doi.org/10.37881/1.511
2020, Volume 5, Issue 1 (January-April) [Download Full PDF]
- Urgent health challenges for the next decade 2030: World Health Organization https://doi.org/10.37881/1.512
2020, Volume 5, Issue 1 (January-April) [Download Full PDF]
- Lamotrigine and Phenytoin indicated for epilepsy recalled by the manufacturer in America https://doi.org/10.37881/1.513
2020, Volume 5, Issue 1 (January-April) [Download Full PDF]
- Traditional Approaches and Medicinal Plants in Treatment of Epilepsy in West and East Africa https://doi.org/10.37881/1.521
2020, Volume 5, Issue 2 (May-August) [Download Full PDF]
- COVID-19 in the Shaqra, Saudi Arabia: prevalence and prevention strategies https://doi.org/10.37881/1.531
2020, Volume 5, Issue 3 (September-December) [Download Full PDF]
- The variation in the reduced glutathione levels of red blood cells between full- term Libyan newborns with hyperbilirubinemia https://doi.org/10.37881/1.532
2020, Volume 5, Issue 3 (September-December) [Download Full PDF]